Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals. - Wikidata - awgldk - TriplyDB

Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals.

Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals.

http://www.wikidata.org/entity/Q34803558

about

N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action Using glutamate homeostasis as a target for treating addictive disorders The effect of N-acetylcysteine in the nucleus accumbens on neurotransmission and relapse to cocaine The neurobiology and genetics of impulse control disorders: relationships to drug addictions Glutamatergic substrates of drug addiction and alcoholism Thinking outside the cleft to understand synaptic activity: contribution of the cystine-glutamate antiporter (System xc-) to normal and pathological glutamatergic signaling Glutamate Transporter GLT-1 as a Therapeutic Target for Substance Use Disorders New treatments for cocaine dependence: a focused review Potential role of N-acetylcysteine in the management of substance use disorders Metabotropic glutamate receptors: from the workbench to the bedside.N-acetyl cysteine treatment rescues cognitive deficits induced by mitochondrial dysfunction in G72/G30 transgenic mice Pharmacological means of reducing human drug dependence: a selective and narrative review of the clinical literature.Cocaine-induced neuroadaptations in glutamate transmission: potential therapeutic targets for craving and addiction Drug-induced plasticity contributing to heightened relapse susceptibility: neurochemical changes and augmented reinstatement in high-intake rats.N-acetylcysteine (NAC) in young marijuana users: an open-label pilot study Clinical case discussion: binge eating disorder, obesity and tobacco smoking.Cognitive enhancers in the treatment of substance use disorders: clinical evidence.Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.Repeated N-acetylcysteine administration alters plasticity-dependent effects of cocaine.Milk thistle seed extract protects rat C6 astroglial cells from acute cocaine toxicity.N-acetylcysteine in the treatment of psychiatric disorders: current status and future prospects.An open-label pilot trial of N-acetylcysteine and varenicline in adult cigarette smokers.Glutamatergic targets for enhancing extinction learning in drug addiction Redox-based epigenetic status in drug addiction: a potential contributor to gene priming and a mechanistic rationale for metabolic intervention.N-acetyl cysteine mitigates the acute effects of cocaine-induced toxicity in astroglia-like cells.Cognitive enhancers for facilitating drug cue extinction: insights from animal models.Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure.A double-blind placebo-controlled trial of N-acetylcysteine in the treatment of cocaine dependence Pharmacological treatment of cannabis dependence.Glutathione and redox signaling in substance abuse.The effects of N-Acetylcysteine on frontostriatal resting-state functional connectivity, withdrawal symptoms and smoking abstinence: A double-blind, placebo-controlled fMRI pilot study.Marijuana craving trajectories in an adolescent marijuana cessation pharmacotherapy trial.N-acetylcysteine decreased nicotine self-administration and cue-induced reinstatement of nicotine seeking in rats: comparison with the effects of N-acetylcysteine on food responding and food seeking Blunted cystine-glutamate antiporter function in the nucleus accumbens promotes cocaine-induced drug seeking.N-Acetylcysteine in the treatment of pediatric trichotillomania: a randomized, double-blind, placebo-controlled add-on trial.The effects of cocaine on different redox forms of cysteine and homocysteine, and on labile, reduced sulfur in the rat plasma following active versus passive drug injections.A targeted review of the neurobiology and genetics of behavioural addictions: an emerging area of research.Hypothesis-driven medication discovery for the treatment of psychostimulant addiction Glutamatergic medications for the treatment of drug and behavioral addictions.Systematic review of N-acetylcysteine in the treatment of addictions.

P2860

Q24615952-F9C0FBAD-620B-450D-B1AF-19925C7B883C Q24619198-FF2F1681-4695-4931-9667-FC051E60A1C6 Q24631216-929E68B8-A0A5-495F-9B97-9BC028396E5D Q24642641-BA27989C-667D-47FF-8348-FD6E5623CCD8 Q24648924-969ACD34-9DF8-4FCA-A5E6-89D7B444BA31 Q26864995-B7080243-D79C-417A-B00A-9216F916FCC9 Q28081726-9DAAC155-E316-4DC4-9F9F-E0CA54B550B0 Q28252765-06B51A34-95AA-47AA-8E8F-6A923DD59945 Q28306130-D2CD11A3-502D-4DFC-85D4-261AF991E186 Q30448778-FF59FEB9-88D3-4A52-9CF8-9232E6700D0C Q30504497-48C2347B-E1DF-4398-97F5-3CFE679E1D08 Q33582063-8D1550AB-0EFC-4A2D-87DE-EFFC7415E6F6 Q33626978-BF81780D-330F-4B75-88F8-F3E41C6C2D7D Q33660418-6166D0DF-DC68-46E0-B18B-509659D10E05 Q33679951-F4D39536-3145-48D3-A744-A05B01357FEF Q33814959-257BF925-C0B3-4BD6-A12C-DECA67D33BC6 Q34183988-D75AFF7B-C665-485A-AB67-85075E4FD255 Q34253787-809CF8FF-F3F3-4DD7-9452-ECF6E860B3CE Q34378304-E506FE56-FD12-48E8-8EDC-725485191BE0 Q34426848-AB26FE75-4660-4883-A89B-83F530683B56 Q34543171-C48773CE-4DCA-4796-8885-93B9C8336BEC Q34675076-12C52B27-B73E-4112-9FC4-007A5103FF6B Q34829339-D3EB6B7A-860B-48AF-B589-114CB8360B3C Q34999412-51E06666-63FB-4CC8-BB4D-F3129E26E0B3 Q35008949-35234DE1-5ADC-4E31-8944-EBD5422C7A31 Q35043180-FF8BE472-3F1F-4FC7-94CC-368304942938 Q35103785-0C7F3BAC-D60B-4B5C-8108-47673FFDA573 Q35144056-569D6FD4-E80E-4000-8EA7-E97F97DC0E84 Q35210350-DF8CE016-FA2F-4D0D-AF85-8184A49C0CF1 Q35683084-39D1DE84-B517-4A00-86D8-D8CE5A496DE5 Q36248846-0753B015-4ACA-4DBA-AEB4-612F3A21AABD Q36572334-001F3A8B-18E4-423B-BE23-7CA363F0A589 Q36971440-01E3553F-E2F2-4106-A9D6-1CB1B19982F2 Q37038018-122EC5D2-EC84-4D03-B5DC-302FECAA92EA Q37098899-F41A480E-50DE-4BC1-9CD0-C7BF260B3969 Q37121626-72DC4F37-2DF9-4A83-A312-6C82F9C208CF Q37146962-E9D54D1A-EAD7-45DE-80DD-1E9299E32133 Q37183687-E5EF4494-0463-4157-8D1A-626DEF2EBD09 Q37871133-1562DB0C-EE3C-4359-BA8A-F94A33881FC4 Q38199954-EE76545A-EFEF-43E1-8AB5-DC0B6BA221AD

P2860

Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals.

http://www.wikidata.org/entity/Q34803558

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals.

@ast

Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals.

@en

Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals.

@nl

type

label

Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals.

@ast

Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals.

@en

Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals.

@nl

prefLabel

Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals.

@ast

Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals.

@en

Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals.

@nl

P1433

Q34803558-BF28448E-45AF-4D15-86D0-1738C5084C48

P1476

Q34803558-4E0B8226-76B7-447C-8F2D-053DB379816A

P2093

Q34803558-0B75E03D-D3BF-4785-8B56-A54B54D0750A

Q34803558-2530CEE4-FE7C-4902-8ACF-56D9180E413A

Q34803558-3F702079-6351-4D3A-B781-1781C735D3C2

Q34803558-4A69D04A-85EB-4D25-BFEA-1C0B2337BE7C

Q34803558-998FB756-00DC-40ED-A010-188E545E8CCC

Q34803558-B7F4915E-386D-4B19-A121-C991DB2BDB96

Q34803558-D992A87F-CC0F-49A9-8AAA-BFBC6FD4770C

Q34803558-DBD4B570-5D00-4C5E-AEFB-D3AFDE84FD5E

P2860

Q34803558-0B201496-4F08-4C25-8A80-B752AC036D1F

Q34803558-0D0EE84F-DE8D-476E-815A-092F4A123634

Q34803558-0F362C82-D7E9-4D82-BB11-53365800D60A

Q34803558-1C11542A-738A-47F2-AD50-C91C6F8525F8

Q34803558-1C2DEF1E-DBBA-4BEE-A07A-5CB04897C972

Q34803558-1E826C2C-5FC5-4592-B887-26EBDA3BF81C

Q34803558-45D7E79D-1200-4E27-97C4-69E5B982F791

Q34803558-7230F867-5AC0-41B1-911B-C0E7C41C4E12

Q34803558-791E9AD0-78A6-4C98-A686-9301C8DBB161

Q34803558-7B87F796-EE8F-4403-A65D-16EA7395EEC0

P304

Q34803558-4C41D527-DB83-4E3A-958F-71EF0B018EC0

P31

Q34803558-B44CE2BF-F11E-4490-8C4C-72EC40CB8EE1

P356

Q34803558-5E5E244D-6A78-4996-B7F8-3F7C7164E858

P433

Q34803558-1577F244-D5B5-472B-A918-28F139FAA056

P478

Q34803558-307F59EE-AC83-4BF9-BA52-F2631434A2CB

P50

Q34803558-B1AD7024-8E49-480A-BFAE-700C1E8BE4E4

P577

Q34803558-06921BA7-1C80-405B-B003-73AE580050A7

P5875

Q34803558-EF062C66-79AA-479E-B683-13AF1F1BABF8

P698

Q34803558-A3E8F34B-4B20-4116-9742-CA2BF82960A7

P932

Q34803558-6F6D9CA9-070A-4184-9C45-1BB485DC3481

P356

10550490500419169

P1433

American Journal on Addictions

P1476

Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals

@en

P2093

Aimee McRae

http://www.w3.org/2001/XMLSchema#string

Hugh Myrick

http://www.w3.org/2001/XMLSchema#string

Kathleen Brady

http://www.w3.org/2001/XMLSchema#string

Krista McFarland

http://www.w3.org/2001/XMLSchema#string

Michael Saladin

http://www.w3.org/2001/XMLSchema#string

Pascale Mardikian

http://www.w3.org/2001/XMLSchema#string

Peter Kalivas

http://www.w3.org/2001/XMLSchema#string

Robert Malcolm

http://www.w3.org/2001/XMLSchema#string

P2860

Adverse reactions to acetylcysteine and effects of overdose

Risk factors in the development of adverse reactions to N-acetylcysteine in patients with paracetamol poisoning

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10

Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials.

Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985)

Management of paracetamol overdose: current controversies.

Clinical pharmacokinetics of N-acetylcysteine.

Medical complications of cocaine abuse.

Stroke associated with cocaine abuse--?

Context-specific enhancement of glutamate transmission by cocaine.

P304

105-110

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10550490500419169

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7325075

http://www.w3.org/2001/XMLSchema#string

P698

16449100

http://www.w3.org/2001/XMLSchema#string

P932

1513138

http://www.w3.org/2001/XMLSchema#string